logo I2SE ifrb UFRSMBH

fondateur CC r2020

Logo UP13

2011

Touvier M, Kesse-Guyot E, Andreeva V, Fezeu L, Charnaux N, SuttonA, Druesne-Pecollo N, Hercberg S, Galan P, Zelek L, Latino-Martel P, Czernichow S. n-3 polyunsaturated fatty acid intake modulates the prospective association between plasma intercellular adhesion molecule 1 and cancer risk: a nested case-control study. Journées Francophones de Nutrition, 9/12/2011, Reims, France

Suffee N, Aid R, Le visage C, Hlawaty H, Haddad O, Martin L, Louedec L, Laguillier C, Richard B, Oudar O, Letourneur D, Charnaux N, Sutton A. Pullulan/dextran delivery RANTES/CCL5 in in vivo model of ischemia mice leg exerts pro-angiogenic effects in, in vitro and in vivo models through its oligomerization and binding glycosaminoglycans. Congrès de Bioadhésion, biocontamination des surfaces, 12-14 octobre 2011, Nice, France.

Suffee N, Meddahi-Pelle A, Hlawaty H, Haddad O, Martin L, Maillard L, Louedec L, Laguillier C, Richard B, Oudar O, Letourneur D, Charnaux N, Sutton A. RANTES/CCL5 exerts pro-angiogenic effects in, in vitro and in vivo models through its oligomerization and binding glycosaminoglycans. Congrès Advances in the cellular and molecular biology of angiogenesis, 27-29 juin 2011, Birmingham, Angleterre.

Nahon P, Sutton A, Rufat P, Charnaux N, Mansouri A, Moreau R, Ganne-Carrié N, Grando-Lemaire V, N’Kontchou G, Trinchet JC,Pessayre D, Beaugrand M. Le variant 2G-403 dans le promoteur de la myeloperoxidase augmente le risque de survenue du carcinome hépatocellulaire au cours de la cirrhose virale C. Journées Francophones d’hépato-gastroentérologie et d’oncologie digestives, 24-27 Mai 2011, Paris, France.

Touvier M, Fezeu L, Ahluwalia N, Julia C, Charnaux N, Sutton A, Méjean C, Latino-Martel P, Hercberg S, Galan P, Czernichow S. Associations between biomarkers of inflammation, endothelial function and adiposity and cancer risk: a prospective study and an evaluation of predictivity performance. Séminaire Nacre (Nutrition Alimentation Cancer Recherche), 15 mai 2011, Lyon, France

Sultana S, Djaker N, Boca-Farcau S, Salerno M, Charnaux N, Astilean S, Hlawaty H, Lamy De La Chapelle M. Physico-chemical aspects, toxicity and in-vitro methods. NanoLinenWorkshop,14-15/12/2011, Paris, France

Suffee N, Aid R, Le visage C, Hlawaty H, Haddad O, Martin L, Louedec L, Laguillier C, Richard B, Oudar O, Letourneur D, Charnaux N, Sutton A. Bioadhésion, biocontamination des surfaces. Pullulan/dextran delivery of RANTES/CCL5 in vivo model of ischemia mice leg.12-14/10/2011, Nice, France

Suffee N, Aid R, Le visage C, Hlawaty H, Haddad O, Martin L, Louedec L, Laguillier C, Richard B, Oudar O, Letourneur D, Charnaux N, Sutton A. Advances in the cellular and molecular biology of angiogenesis. RANTES/CCL5 exerts pro-angiogenic effects in vitro and in vivo models.27-29/06/2011, Birmingham, Angleterre

Nahon P, Sutton A, Rufat P, Charnaux N, Mansouri A, Moreau R, Ganne-Carrié N, Grando-Lemaire V, N’Kontchou G, Trinchet JC,Pessayre D, Beaugrand M. Genetic variants in myeloperoxidase and catalase promoters confer susceptibility to hepatocellular carcinoma occurrence in patients with HCV-related cirrhosis. International Liver Congress (EASL), 30 Mars-3 Avril 2011, Berlin, Allemagne.

Charni F, Sutton A, Rufat P, Grando V, N’Kontchou G, Mansouri A, Ganne-Carrié N, Trinchet JC, Beaugrand M, Charnaux N, NahoN P. Influence of chemokine RANTES promoter dimorphisms on hepatocellular carcinoma occurrence in patients with cirrhosis. International Liver Congress (EASL), 30 Mars-3 Avril 2011, Berlin, Allemagne.